Literature DB >> 17038326

Cyclic GMP-dependent protein kinase Ialpha attenuates necrosis and apoptosis following ischemia/reoxygenation in adult cardiomyocyte.

Anindita Das1, Albert Smolenski, Suzanne M Lohmann, Rakesh C Kukreja.   

Abstract

Cyclic GMP-dependent protein kinases protein kinase G (PKG) Ialpha and PKGIbeta are major mediators of cGMP signaling in the cardiovascular system. PKGIalpha is present in the heart, although its role in protection against ischemia/reperfusion injury is not known. We investigated the direct effect of PKGIalpha against necrosis and apoptosis following simulated ischemia (SI) and reoxygenation (RO) in cardiomyocytes. Adult rat cardiomyocytes were infected with adenoviral vectors containing hPKGIalpha or catalytically inactive mutant hPKGIalphaK390A. After 24 h, the cells were subjected to 90 min of SI and 2 h RO for necrosis (trypan blue exclusion and lactate dehydrogenase release) or 18 h RO for apoptosis studies. To evaluate the role of K(ATP) channels, subgroups of cells were treated with 5-hydroxydecanoate (100 microm), HMR1098 (30 microm), or glibenclamide (50 microm), the respective blockers of mitochondrial, sarcolemmal, or both types of K(ATP) channels prior to SI. The necrosis observed in 33.7 +/- 1.6% of total myocytes in the SI-RO control group was reduced to 18.6 +/- 0.8% by PKGIalpha (mean +/- S.E., n = 7, p < 0.001). The apoptosis observed in 17.9 +/- 1.3% of total myocytes in the SI-RO control group was reduced to 6.0 +/- 0.6% by PKGIalpha (mean +/- S.E., n = 7, p < 0.001). In addition, PKGIalpha inhibited the activation of caspase-3 after SI-RO in myocytes. Myocytes infected with the inactive PKGIalphaK390A mutant showed no protection. PKGIalpha enhanced phosphorylation of Akt, ERK1/2, and JNK, increased Bcl-2, inducible nitric-oxide synthase, endothelial nitric-oxide synthase, and decreased Bax expression. 5-Hydroxydecanoate and glibenclamide abolished PKGIalpha-mediated protection against necrosis and apoptosis. However, HMR1098, had no effect. A scavenger of reactive oxygen species, as well as inhibitors of phosphatidylinositol 3-kinase, ERK, JNK1, and NOS, also blocked PKGIalpha-mediated protection against necrosis and apoptosis. These results show that opening of mitochondrial K(ATP) channels and generation of reactive oxygen species, in association with phosphorylation of Akt, ERK, and JNK, and increased expression of NOS and Bcl-2, play an essential role in the protective effect of PKGIalpha.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17038326     DOI: 10.1074/jbc.M606142200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  cGMP increases antioxidant function and attenuates oxidant cell death in mouse lung microvascular endothelial cells by a protein kinase G-dependent mechanism.

Authors:  R Scott Stephens; Otgonchimeg Rentsendorj; Laura E Servinsky; Aigul Moldobaeva; Rachel Damico; David B Pearse
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-05-07       Impact factor: 5.464

2.  Overexpression of cGMP-dependent protein kinase I (PKG-I) attenuates ischemia-reperfusion-induced kidney injury.

Authors:  Yanzhang Li; Xiaopeng Tong; Hasiyeti Maimaitiyiming; Kate Clemons; Ji-Min Cao; Shuxia Wang
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

Review 3.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

4.  Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide.

Authors:  Fadi N Salloum; Vinh Q Chau; Nicholas N Hoke; Antonio Abbate; Amit Varma; Ramzi A Ockaili; Stefano Toldo; Rakesh C Kukreja
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

5.  Protein kinase G increases antioxidant function in lung microvascular endothelial cells by inhibiting the c-Abl tyrosine kinase.

Authors:  R Scott Stephens; Laura E Servinsky; Otgonchimeg Rentsendorj; Todd M Kolb; Alexander Pfeifer; David B Pearse
Journal:  Am J Physiol Cell Physiol       Date:  2014-01-08       Impact factor: 4.249

Review 6.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

Review 7.  Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection.

Authors:  Rakesh C Kukreja; Fadi N Salloum; Anindita Das
Journal:  J Am Coll Cardiol       Date:  2012-05-29       Impact factor: 24.094

8.  Beet root juice protects against doxorubicin toxicity in cardiomyocytes while enhancing apoptosis in breast cancer cells.

Authors:  Sayantanee Das; Scott M Filippone; Denise S Williams; Anindita Das; Rakesh C Kukreja
Journal:  Mol Cell Biochem       Date:  2016-08-26       Impact factor: 3.396

9.  Antioxidative effect of luteolin pretreatment on simulated ischemia/reperfusion injury in cardiomyocyte and perfused rat heart.

Authors:  Rui-Qu Zhang; Dong-Ye Li; Tong-da Xu; Sha-Sha Zhu; Huan-Jun Pan; Fang Fang; Xin Wu; Hong Sun
Journal:  Chin J Integr Med       Date:  2016-03-08       Impact factor: 1.978

10.  Pharmacological postconditioning by bolus injection of phosphodiesterase-5 inhibitors vardenafil and sildenafil.

Authors:  Bernd Ebner; Annette Ebner; Anna Reetz; Stefanie Böhme; Antje Schauer; Ruth H Strasser; Christof Weinbrenner
Journal:  Mol Cell Biochem       Date:  2013-03-27       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.